Nigella sativa supplementation to treat symptomatic mild COVID-19: A structured summary of a protocol for a randomised, controlled, clinical trial

Nigella sativa supplementation to treat symptomatic mild COVID-19: A structured summary of a protocol for a randomised, controlled, clinical trial

Abstract Objectives To investigate the potential efficacy of Nigella sativa (NS) oil supplementation on the outcomes of patients with mild Coronavirus Disease 2019 (COVID-19). Trial design Prospective, two-arm, parallel-group, randomised (1:1 allocation ratio), open-label, controlled, exploratory ph...

Full description

Bibliographic Details
Main Authors: Abdulrahman E. Koshak, Emad A. Koshak, Abdullah F. Mobeireek, Mazen A. Badawi, Siraj O. Wali, Husam M. Malibary, Ali F. Atwah, Meshari M. Alhamdan, Reem A. Almalki, Tariq A. Madani
Format: Article
Language:English
Published: BMC 2020-08-01
Series:Trials
Subjects:
COVID-19
SARS-CoV-2
Randomised controlled trial
protocol
Nigella sativa
black seed
Online Access:http://link.springer.com/article/10.1186/s13063-020-04647-x

Internet

http://link.springer.com/article/10.1186/s13063-020-04647-x

Similar Items